— Early sign of Alzheimer's reversed in lab — One of the earliest known impairments caused by Alzheimer's disease - loss of sense of smell - can be restored by removing a plaque-forming protein in a mouse model of the disease,…
— Parental controls on embryonic development? — When a sperm fertilises an egg, each contributes a set of chromosomes to the resulting embryo, which at these very early stages is called a zygote. Early on, zygotic genes are inert,…
— Newly discovered heart stem cells make muscle and bone — Researchers have identified a new and relatively abundant pool of stem cells in the heart. The findings in the December issue of Cell Stem Cell, a Cell Press publication, show that…
— BUSM researchers develop blood test to detect membranous nephropathy — Research conducted by a pair of physicians at Boston University School of Medicine (BUSM) and Boston Medical Centre (BMC) has led to the development of a test that can help diagnose…
— New hip implants no better than traditional implants — New hip implants appear to have no advantage over traditional implants, suggests a review of the evidence published on bmj.com today…
— Action needed to improve men's health in Europe — Policies aimed specifically at men are urgently needed to improve the health of Europe's men, say experts on bmj.com today…
— Probiotics reduce infections for patients in intensive care — Traumatic brain injury is associated with a profound suppression of the patient's ability to fight infection. At the same time the patient also often suffers hyper-inflammation, due…
— High blood sugar levels in older women linked to colorectal cancer — Elevated blood sugar levels are associated with an increased risk of colorectal cancer, according to a study led by researchers at Albert Einstein College of Medicine of Yeshiva University.…
— Engineered botulism toxins could have broader role in medicine — The most poisonous substance on Earth - already used medically in small doses to treat certain nerve disorders and facial wrinkles - could be re-engineered for an expanded role in helping…
Operation makes dementia patients faster and smarter
Researchers from the University of Gothenburg and Sahlgrenska University Hospital are the first in the world to show that an operation can help patients with dementia caused by white matter changes and hydrocephalus.
Presented in the American Journal of Neurosurgery, the results are based on the world's first study to demonstrate the effects of a shunt operation using a placebo control. 14 patients were followed for an average of three and a half years after the operation, with half being given a non-functioning shunt - in other words a sham operation - and the other half a functioning shunt. This is the equivalent to the placebo given in drug trials to determine how much of the treatment's effect is down to the patient's and others' expectations.
'For obvious reasons, this is problematic in a surgical context and surgical placebo studies are highly unusual,' says Magnus Tisell, docent at the Sahlgrenska Academy and consultant neurosurgeon at Sahlgrenska University Hospital. 'However, if you can actually do this kind of study, the level of evidence is the highest possible - class 1.'
The researchers found that patients' mental functions and ability to walk improved tangibly after having a shunt inserted. Half were given an open shunt right from the start and showed immediate improvement, while the other half were initially given a closed shunt and improved only after three months when the shunt was opened.
'Shunt operations have long been used for hydrocephalus, but this study offers more scientifically conclusive results to support the effect of the treatment, and also shows that shunt operations can help far more patients than previously believed with their walking and memory,' says Tisell.
Surgery is not generally used today for patients with hydrocephalus and white matter changes. But the researchers' findings pave the way for a brand new group of patients who could benefit from a shunt operation.
'We believe that far more patients than is currently the case could benefit from a shunt operation, which will require more resources,' says Tisell. 'We also need to find out more about which patients are good candidates for the operation and which shunt is best in each particular case.'
Or subscribe for our Newsletter, a free e-mail publication. It is published practically every day.
Seasonal affective disorder may be linked to genetic mutation
CSIRO ready to commercialise new GI technology
'Opt out' system could solve donor organ shortage
Our diet gives deadly bacteria a target